Prodeon Medical, Inc.
Elaine Aplaon is an accomplished professional in regulatory affairs with a career spanning over two decades. Currently serving as the Sr. Manager of Regulatory Affairs at Prodeon Medical since March 2021, Elaine has held progressive roles at various organizations including Shockwave Medical, Inc. and Intersect ENT, Inc. Elaine's expertise encompasses positions such as Sr. Principal Regulatory Affairs Specialist and Principal Regulatory Affairs Associate. Prior to these roles, Elaine accumulated valuable experience at companies like Avantis Medical Systems and CryoVascular Systems/Boston Scientific Los Gatos. With a foundational background in biology from San Francisco State University, Elaine has demonstrated a strong commitment to regulatory compliance and quality assurance throughout a diverse career in the medical industry.
This person is not in any teams
Prodeon Medical, Inc.
Our program was initially started in 2016 with the mission of reimagining how men can be more easily treated for one of the most common disease states in the world affecting men, Benign Prostatic Hyperplasia (BPH). Prodeon Medical, Inc. has developed and is investigating a minimally invasive and patient-friendly approach to treating Lower Urinary Tract Symptoms (LUTS) due to BPH The procedure, known as the PURE™ (Prostatic Urethral REshaping) procedure uses the investigational the Urocross™ Expander System and Retrieval Sheath to relieve symptoms associated with BPH. Caution: The Urocross Expander System and Retrieval Sheath are for investigational use only under the Expander-2 Clinical Trial (NCT: 05400980) and are not for sale in the U.S. or outside the U.S.